ST天圣 (002872)
Tiansheng Pharmaceutical Group Co.,LTD.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 31800.00
- Circulating A-Shares(W): 21491.81
- Earnings Per Share(RMB): -0.1426
- Net Assets Per Share(RMB): 6.1686
- Operating Revenue(W RMB): 34881.10
- Total Profit(W RMB): -4706.03
- Net Profit Attributable to Parent(W RMB): -4533.94
- Net Profit Growth Rate(%): -24.72
- Weighted Return on Equity(%): -2.2900
- Operating Cash Flow Per Share(RMB): 0.0090
- Undistributed Profit Per Share(RMB): 0.2945
- Capital Reserve Per Share(RMB): 4.4050
2. Main Business
The main business covers:
- Drug research and development
- Drug production
- Drug sales
- Chinese herbal medicine cultivation and processing
3. Company Basic Information
- Company Name: Tiansheng Pharmaceutical Group Co., Ltd.
- Listing Date: 2017-05-19
- Industry: Pharmaceutical Manufacturing
- Address: Chaoyang Industrial Park (Dianjiang Guixi), Chongqing
- Website: www.tszy.com.cn
- Company Profile：The company was established by Chongqing Tiansheng Pharmaceutical Co., Ltd. through a corporate restructuring. The restructuring was based on the audited net assets as of September 30, 2007, amounting to RMB 151,366,764.43, after deducting the production development fund of RMB 20,610,742.78. The owner's equity was converted into total shares of 85,000,000 at a conversion ratio of 1:0.650065664. On December 29, 2007, the company completed the industrial and commercial change registration procedures at the Chongqing Administration for Industry and Commerce and obtained the Business License with registration number 500231000001009.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Chongqing Yudian State-owned Assets Management Group Co., Ltd. | General Legal Person | 1379.23 | 6.42 |
| 2 | Tibet Runfu Air Treatment Engineering Technology Co., Ltd. | General Legal Person | 317.60 | 1.48 |
5. Concept Sectors
- ST Sector
- Below Net Asset Value
- Below IPO Price
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information